Trial

TMC207-TiDP13-C209: Trial to Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized MDR-TB treatment Regimen in Patients With Sputum Smear-positive Pulmonary MDR-TB (Ph

Study Director
Start Date
7 / 2009
Trial Phase
Trial Status
published
Current Enrollment
Target Enrollment
225
Overview
Compound Associations